Pricing Log in Create free account
Friday 6 November 2026 Export BDX’s income statement to Excel — free account

Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

Revenue
−10.5%
EPS
+48.5%
Free cash flow
−31.6%
Total debt
−23.8%

Quarter to September 2026, against a year earlier

212.21 1.34 −0.63%
Market cap
$58.2B
P/E
51.1×
Fwd P/E
39.2×
Dividend yield
1.87%
F-score
6/9
Altman Z
n/a
Beneish M
−2.76
Dividend safety
51/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Becton, Dickinson and Company 8-K filed Oct 15, 2025

Period ended Oct 9, 2025 · Filed · accepted 4:18 PM ET · Document on sec.gov · Filing index

2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits

Nothing in this filing raised a red flag, and we have no summary of it. The items it reports are listed above; the document itself is on sec.gov.

Read the filing on sec.gov The press release